1. Negative regulators of cell death pathways in cancer: perspective on biomarkers and targeted therapies
   Ali Razaghi et al, 2018, Apoptosis CrossRef
2. Synergistic anti-tumor effect of 17AAG with the PI3K/mTOR inhibitor NVP-BEZ235 on human melanoma
   R. Calero et al, 2017, Cancer Letters CrossRef
3. Unbiased High-Throughput Drug Combination Pilot Screening Identifies Synergistic Drug Combinations Effective against Patient-Derived and Drug-Resistant Melanoma Cell Lines
   David A. Close et al, 2021, SLAS Discovery CrossRef
4. Aurora kinase B inhibition reduces the proliferation of metastatic melanoma cells and enhances the response to chemotherapy
   Letizia Porcelli et al, 2015, Journal of Translational Medicine CrossRef
5. Update on advanced melanoma treatments: small molecule targeted therapy, immunotherapy, and future combination therapies
   Andrew Kwong et al, 2019, Wiener Medizinische Wochenschrift CrossRef
6. Gene Expression–Based Molecular Test as Diagnostic Aid for the Differential Diagnosis of Psoriasis and Eczema in Formalin-Fixed and Paraffin-Embedded Tissue, Microbiopsies, and Tape Strips
   Felix Fischer et al, 2023, Journal of Investigative Dermatology CrossRef
7. Leveraging multi-way interactions for systematic prediction of pre-clinical drug combination effects
   Heli Julkunen et al, 2020, Nature Communications CrossRef
8. Dietary sulforaphane inhibits histone deacetylase activity in B16 melanoma cells
   Wu Yuanfeng et al, 2015, Journal of Functional Foods CrossRef
9. NF-κB inhibition is associated with OPN/MMP-9 downregulation in cutaneous melanoma
   Claudio Guarneri et al, 2017, Oncology Reports CrossRef
10. Computed determination of the in vitro optimal chemocombinations of sphaeropsidin A with chemotherapeutic agents to combat melanomas
    Aude Ingels et al, 2017, Cancer Chemotherapy and Pharmacology CrossRef
11. Naringin suppresses the metabolism of A375 cells by inhibiting the phosphorylation of c-Src
    Bingyu Guo et al, 2016, Tumor Biology CrossRef
12. mTOR inhibitor Everolimus-induced apoptosis in melanoma cells
    Dorota Ciołczyk-Wierzbicka et al, 2019, Journal of Cell Communication and Signaling CrossRef
13. Proteasome inhibitors against amelanotic melanoma
    Justyna Sidor-Kaczmarek et al, 2017, Cell Biology and Toxicology CrossRef
14. The protein kinase IKKepsilon contributes to tumour growth and tumour pain in a melanoma model
    Christine V. Möser et al, 2016, Biochemical Pharmacology CrossRef
15. Model Affitin and PEG modifications onto siRNA lipid nanocapsules: cell uptake and in vivo biodistribution improvements
    Pauline Resnier et al, 2019, RSC Advances CrossRef
16. The role of the ubiquitin-proteasome pathway in skin cancer development: 26S proteasome-activated NF-κB signal transduction
    Ouadie Mohamed El Yaagoubi et al, 2021, Cancer Biology & Therapy CrossRef
17. Discovery of novel anti-angiogenesis agents. Part 7: Multitarget inhibitors of VEGFR-2, TIE-2 and EphB4
    Chuansheng Li et al, 2017, European Journal of Medicinal Chemistry CrossRef
18. Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune Therapy
    Stuart Gallagher et al, 2015, Cancers CrossRef
19. Efficient ferrocifen anticancer drug and Bcl-2 gene therapy using lipid nanocapsules on human melanoma xenograft in mouse
    Pauline Resnier et al, 2017, Pharmacological Research CrossRef
20. Synergistic targeted inhibition of MEK and dual PI3K/mTOR diminishes viability and inhibits tumor growth of canine melanoma underscoring its utility as a preclinical model for human mucosal melanoma
    Bih‐Rong Wei et al, 2016, Pigment Cell & Melanoma Research CrossRef
21. Chronic Resveratrol Treatment Inhibits MRC5 Fibroblast SASP-Related Protumoral Effects on Melanoma Cells
    Beatrice Menicacci et al, 2017, The Journals of Gerontology: Series A CrossRef
22. Possibilities for the Therapy of Melanoma: Current Knowledge and Future Directions
    Marcela Valko-Rokytovská et al, 2018, Human Skin Cancers - Pathways, Mechanisms, Targets and Treatments CrossRef
23. Tetrahydroquinoline/4,5-dihydroisoxazole hybrids with a remarkable effect over mitochondrial bioenergetic metabolism on melanoma cell line B16F10
    Luis C. Vesga et al, 2021, Medicinal Chemistry Research CrossRef
24. A novel molecular disease classifier for psoriasis and eczema
    Natalie Garzorz‐Stark et al, 2016, Experimental Dermatology CrossRef
25. SPOC domain proteins in health and disease
    Lisa-Marie Appel et al, 2023, Genes & Development CrossRef
26. Association of CDK4 germline and BRAF somatic mutations in a patient with multiple primary melanomas and BRAF inhibitor resistance
    Maurizio Governa et al, 2015, Melanoma Research CrossRef